1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-amine

Catalog No. :
ACQMGY401
CAS No. :
1190380-49-4
Molecular Formula :
C8H13N3O
Molecular Weight :
167.21

IUPAC Name:1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-amine

1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$99.00Login to see priceIn stockIn stock
5g98%$334.00Login to see priceIn stockIn stock
25g98%$1296.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-amine
IUPAC Name1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-amine
MDL No.MFCD11505007
Molecular FormulaC8H13N3O
Molecular Weight167.21
SMILESNC1=CN(C2CCOCC2)N=C1
InChI KeyGZZNBQLBGSVOOZ-UHFFFAOYSA-N
Synonym1190380-49-4 | 1-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-PYRAZOL-4-AMINE | 1-(oxan-4-yl)pyrazol-4-amine | 1-Tetrahydro-2H-pyran-4-yl-1H-pyrazol-4-amine | 1-(Oxan-4-yl)-1H-pyrazol-4-amine | 1-(Tetrahydropyran-4-yl)pyrazol-4-amine | 1H-Pyrazol-4-amine, 1-(tetrahydro-2H-pyran-4-y
CAS No.1190380-49-4
PubChem CID51063703

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQMGY401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQMGY401 route product structure diagram
    ACQMGY4011190380-49-4 In Stock
Inquiry

2. ACQMGY401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACQMGY401 route product structure diagram
    ACQMGY4011190380-49-4 In Stock
Inquiry

Comments (0)